BIOFORM MEDICAL, INC. INDEMNIFICATION AGREEMENTIndemnification Agreement • August 20th, 2007 • Bioform Medical Inc • Delaware
Contract Type FiledAugust 20th, 2007 Company JurisdictionTHIS AGREEMENT is entered into, effective as of _____________, 2007 by and between BioForm Medical, Inc., a Delaware corporation (the “Company”), and __________ (“Indemnitee”), effective as of the date that the Registration Statement on Form S-1 related to the initial public offering of the Company’s Common Stock is declared effective by the United States Securities and Exchange Commission.
SETTLEMENT AND LICENSE AGREEMENTSettlement and License Agreement • August 20th, 2007 • Bioform Medical Inc • California
Contract Type FiledAugust 20th, 2007 Company JurisdictionThis SETTLEMENT AND LICENSE AGREEMENT (the “Agreement”) is entered into effective as of the 31st day of October 2005 (the “Effective Date”) by BioForm Medical, Inc., a Delaware corporation, and BioForm Medical Europe B.V., a Netherlands Corporation (together “BioForm”), Artes Medical USA, Inc., a Delaware corporation (“Artes”) and Dr. Martin Lemperle, a German national residing at **** Frankfurt am Main, Federal Republic of Germany (“Lemperle”).
LEASELease • August 20th, 2007 • Bioform Medical Inc • Wisconsin
Contract Type FiledAugust 20th, 2007 Company JurisdictionSELLER GRANTS THIS OPTION, THE WARRANTIES, REPRESENTATIONS AND COVENANTS MADE IN THIS OPTION SURVIVE CLOSING AND THE CONVEYANCE OF THE PROPERTY. THE UNDERSIGNED HEREBY AGREES TO CONVEY THE ABOVE-MENTIONED PROPERTY ON THE TERMS AND CONDITIONS AS SET FORTH HEREIN AND ACKNOWLEDGES RECEIPT OF A COPY OF THIS OPTION.
BIOFORM MEDICAL, INC. AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • August 20th, 2007 • Bioform Medical Inc • California
Contract Type FiledAugust 20th, 2007 Company JurisdictionTHIS AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”) is made as of June 28, 2006, by and between BioForm Medical, Inc., a Delaware corporation (the “Company”) and the individuals and entities listed on Exhibit A (the “Investors”) by virtue of the execution of this Agreement by the holders of at least a majority of the Registrable Securities outstanding and subject to the Amended and Restated Investors’ Rights Agreement dated February 12, 2004 (the “Original Agreement”). This Agreement hereby amends and restates in its entirety the Original Agreement.